Shopping Cart
- Remove All
Your shopping cart is currently empty
Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $478 | In Stock | |
| 5 mg | $1,390 | In Stock | |
| 10 mg | $2,280 | In Stock |
| Description | Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas. |
| Synonyms | RO7082859, RG 6026, CD20-TCB |
| Molecular Weight | 170.37 kDa |
| Cas No. | 2229047-91-8 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.